• A study testing omaveloxolone compared to placebo for children and adolescents aged 2 to 15 years with Friedreich’s ataxia

    Recruiting

    3 1
    Investigated drugs:
    Austria Denmark France Germany Ireland Italy +2
  • Study of Lisocabtagene Maraleucel as First Treatment for Adults with Primary Central Nervous System Lymphoma Who Cannot Have a Stem Cell Transplant

    Recruiting

    2 1 1 1
    Investigated diseases:
    France Germany
  • A Study of Fesoterodine and 5-[(1R,5R)-3-Azabicyclo[3.

    Recruiting

    2 1
    Bulgaria Czechia France Hungary Italy Poland +3
  • A study comparing datopotamab deruxtecan with durvalumab versus datopotamab deruxtecan alone for patients with PDL1-negative metastatic triple-negative breast cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Germany Spain
  • A study comparing dotinurad and allopurinol for lowering uric acid levels in adults with gout and high uric acid in the blood.

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Poland Spain
  • A study testing ALXN2030 for adults with antibody-mediated rejection after kidney transplantation

    Recruiting

    2 1
    Investigated diseases:
    Spain
  • Study of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer

    Recruiting

    3 1 1 1
    Belgium Denmark France Germany Greece Hungary +6
  • Study of BNT326 alone and with BNT327 in patients with advanced solid tumors: Testing safety and effectiveness of new cancer treatments

    Recruiting

    1 1 1
    Investigated diseases:
    Belgium Germany Italy Spain
  • Study of Axatilimab compared to standard therapy in children with chronic graft-versus-host disease who have previously received at least 2 treatments

    Recruiting

    2 1 1
    Investigated drugs:
    Belgium Germany Italy Spain
  • Study of KarXT (trospium chloride and xanomeline tartrate) and KarX-EC (xanomeline tartrate) for cognitive impairment in mild to moderate Alzheimer’s disease

    Recruiting

    3 1
    Investigated diseases:
    Finland France Germany Greece Italy The Netherlands +4

powered by